Congenital Anomalies Treatment Market - Top Companies and Manufacturers

Companies Dominating the Congenital Anomalies Treatment Landscape

Johnson & Johnson Services, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
GlaxoSmithKline plc.
Regeneron Pharmaceuticals, Inc.
BioMarin Pharmaceutical Inc.
Amgen Inc.
Alexion Pharmaceuticals, Inc.
Merck KGaA
Novartis International AG
Ipsen Pharma
Fresenius Kabi USA

Browse Key Market Insights with Data Illustration:

Congenital Anomalies Treatment Market Size & Share, Forecast Report 2036

In the News

December 20, 2021: Merck KGaA announced the acquisition of Chord Therapeutics to expand its neuro-inflammatory pipeline, to develop cladribine drug.
December 01, 2020: Fresenius Kabi launched a new Icatibant injection to treat acute attacks of hereditary angioedema in adults. Icatibant injection is an FDA-approved, cost-effective and quick-relief alternative to treat attacks of hereditary angioedema (HAE).

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of congenital anomalies treatment is estimated at USD 164.33 million.

Congenital Anomalies Treatment Market size was valued at USD 158.5 million in 2023 and is likely to reach USD 284.41 million by 2036, registering around 4.6% CAGR during the forecast period i.e., between 2024-2036. Increasing prevalence of congenital anomalies will boost the market growth.

Asia Pacific is poised to dominate majority revenue share by 2036, on the back of advancements in the healthcare sector, and rising healthcare expenditure across the region.

The major players in the market are GlaxoSmithKline plc, Regeneron Pharmaceuticals, Inc., BioMarin Pharmaceutical Inc., Amgen Inc., Alexion Pharmaceuticals, Inc., Merck KGaA, Novartis International AG, Ipsen Pharma, Fresenius Kabi USA, and others.

Congenital Anomalies Treatment Market - Top Companies and Manufacturers

Companies Dominating the Congenital Anomalies Treatment Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What is the size of the congenital anomalies treatment market?

Why is the congenital anomalies treatment sector gaining traction in near future?

Which region accounted for the largest congenital anomalies treatment industry share?

Who are the major congenital anomalies treatment players?